RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML)

Clinical trials for RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML) explained in plain language.

Never miss a new study

Get alerted when new RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML) trials appear

Sign up with your email to follow new studies for RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for leukemia patients when standard treatments fail

Disease control Recruiting now

This study is testing whether adding a drug called venetoclax to a standard chemotherapy combination works better for adults with acute myeloid leukemia (AML) that has returned or not responded to prior treatment. Researchers want to see if this approach helps clear more cancer c…

Matched conditions: RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML)

Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML)

Get alerted when new RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML) trials appear

New hope for leukemia patients when standard treatments fail